Abou-Alfa, G. K., Geyer, S. M., Nixon, A. B., Innocenti, F., Shi, Q., Kumthekar, P., Jacobson, S., El Dika, I., Yaqubie, A., Lopez, J., Huang, B., Tang, Y.-W., Wen, Y., Schwartz, L. H., El-Khoueiry, A. B., Knox, J. J., Rajdev, L., Bertagnolli, M. M., Meyerhardt, J. A., … Venook, A. P. (2024). CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer Research Communications, 4(3), 682–690. https://doi.org/10.1158/2767-9764.crc-22-0516
Columbia Affiliation:
Subjects:
Carcinoma, Hepatocellular
(MeSH)
Antineoplastic Agents
(MeSH)
Liver Neoplasms
(MeSH)
Hepatitis C
(MeSH)
Hepatitis C Infection and Treatment
(OpenAlex Topic)
Hepatocellular Carcinoma
(OpenAlex Topic)
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1158/2767-9764.crc-22-0516
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex